Nutex Health Inc.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
NUTX$194.16+7.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| · · Year ended December 31, | |||||||||
| | 2024 | 2023 | 2022 | ||||||
| Revenue: | | | | | | | | | |
| Hospital division | | $449,063,683 | | $218,070,397 | | $198,508,245 | |||
| Population health management division | | | 30,884,950 | | | 29,575,919 | | | 20,786,061 |
| Total revenue | | | 479,948,633 | | | 247,646,316 | | | 219,294,306 |
| | | | | | | | | | |
| Operating costs and expenses: | | | | | | | | ||
| Payroll | | | 117,527,022 | | | 108,377,938 | | | 111,785,110 |
| Contract services | | | 100,757,191 | | | 42,349,982 | | | 35,913,441 |
| Medical supplies | | | 15,285,481 | | | 14,151,140 | | | 12,118,893 |
| Depreciation and amortization | | 18,971,972 | | 17,591,572 | | 13,131,374 | |||
| Other | | | 31,145,690 | | | 30,401,513 | | | 30,923,750 |
| Total operating costs and expenses | | | 283,687,356 | | | 212,872,145 | | | 203,872,568 |
| | | | | | | | | | |
| Gross profit | | | 196,261,277 | | | 34,774,171 | | | 15,421,738 |
| | | | | | | | | | |
| Corporate and other costs: | | | | | | | | | |
| Facilities closing costs | | | - | | | 217,266 | | | - |
| Acquisition costs | | | - | | | 43,464 | | | 3,885,666 |
| Stock-based compensation | | | 16,631,898 | | | 2,835,971 | | | 189,581 |
| Impairment of assets | | | 3,887,216 | | | 29,082,203 | | | - |
| Impairment of goodwill | | | 3,197,391 | | | 1,139,297 | | | 398,135,038 |
| General and administrative expenses | | | 41,923,972 | | | 33,229,718 | | | 19,810,607 |
| Total corporate and other costs | | | 65,640,477 | | | 66,547,919 | | | 422,020,892 |
| | | | | | | | | | |
| Operating income (loss) | | 130,620,800 | | | (31,773,748) | | | (406,599,154) | |
| | | | | | | | | | |
| Interest expense, net | | | 19,932,015 | | | 16,317,869 | | | 12,490,260 |
| Loss on warrant liability | | | 1,608,973 | | | - | | | - |
| Other (income) expense | | (668,930) | | 399,182 | | 559,299 | |||
| Income (loss) before taxes | | | 109,748,742 | | | (48,490,799) | | | (419,648,713) |
| | | | | | | | | | |
| Income tax (benefit) expense | | | 14,476,821 | | | (5,067,084) | | | 13,090,905 |
| | | | | | | | | | |
| Net income (loss) | | | 95,271,921 | | | (43,423,715) | | | (432,739,618) |
| | | | | | | | | | |
| Less: net income (loss) attributable to noncontrolling interests | | | 43,092,753 | | | 2,362,899 | | | (7,959,172) |
| | | | | | | | | | |
| Net income (loss) attributable to Nutex Health Inc. | | $52,179,168 | | $(45,786,614) | | $(424,780,446) | |||
| | | | | | | | | | |
| Earnings (loss) per common share | | | | | | | | | |
| Basic | | $10.25 | | $(10.39) | | $(100.36) | |||
| Diluted | | $9.71 | | $(10.39) | | $(100.36) | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.